These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 2837853

  • 1. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
    Shabtai M, Luft B, Waltzer WC, Anaise D, Rapaport FT.
    Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
    Watson FS, O'Connell JB, Amber IJ, Renlund DG, Classen D, Johnston JM, Smith CB, Bristow MR.
    J Heart Transplant; 1988 Jun; 7(2):102-5. PubMed ID: 2835468
    [Abstract] [Full Text] [Related]

  • 3. DHPG (Gancyclovir) improves survival in CMV pneumonia.
    Mai M, Nery J, Sutker W, Husberg B, Klintmalm G, Gonwa T.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
    Cantarovich M, Hiesse C, Lantz O, Fassi-Fihri S, Charpentier B, Fries D.
    Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
    [No Abstract] [Full Text] [Related]

  • 5. DHPG treatment of kidney transplant recipients with severe CMV infection.
    Lang P, Buisson C, Rostoker G, Ben Maadi A, Fruchaud G, Deforge L, Chopin D, Abbou C, Romano P, Fleury J.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
    [No Abstract] [Full Text] [Related]

  • 6. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
    Hecht DW, Snydman DR, Crumpacker CS, Werner BG, Heinze-Lacey B.
    J Infect Dis; 1988 Jan; 157(1):187-90. PubMed ID: 2826608
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
    Verdonck LF, de Gast GC, Dekker AW, de Weger RA, Schuurman HJ, Rozenberg-Arska M.
    Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
    Ho WG, Winston DJ, Champlin RE.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
    [No Abstract] [Full Text] [Related]

  • 10. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B, Lamy ME, Salizzoni M, Cornu C, Mostin J, Fevery J, De Groote V, Otte JB.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus myocarditis as a cause of cardiac dysfunction in a heart transplant recipient.
    Gonwa TA, Capehart JE, Pilcher JW, Alivizatos PA.
    Transplantation; 1989 Jan; 47(1):197-9. PubMed ID: 2536201
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M, Pirson Y, Squifflet JP, Lamy M, Gianello P, Alexandre GP.
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [Abstract] [Full Text] [Related]

  • 15. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH.
    JAMA; 1987 Jun 12; 257(22):3082-7. PubMed ID: 3035246
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
    Schmidt GM, Kovacs A, Zaia JA, Horak DA, Blume KG, Nademanee AP, O'Donnell MR, Snyder DS, Forman SJ.
    Transplantation; 1988 Dec 12; 46(6):905-7. PubMed ID: 2849818
    [No Abstract] [Full Text] [Related]

  • 18. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID, Syriopoulou VP, Chelioti H, Daikos GL, Stamatiades D, Kostakis A, Boletis JN.
    Clin Microbiol Infect; 2005 Sep 12; 11(9):736-43. PubMed ID: 16104989
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.